{"id":"W2337001617","doi":"10.1007/s10637-016-0351-x","title":"A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Irinotecan; Medicine; Tolerability; Internal medicine; Regimen; Oncology; Neutropenia; PARP inhibitor; Colorectal cancer; Cancer; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001971608,0.001542357,0.002488875,0.0005447629,0.00103275,0.001195682,0.001211797,0.001481524,0.005540517],"category_scores_gemma":[0.00129145,0.0006816042,0.002291899,0.00119932,0.001365002,0.0005792364,0.0004476326,0.004102436,0.0008246754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004946951,"about_ca_system_score_gemma":0.01403036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1016788,"about_ca_topic_score_gemma":0.3116298,"domain_scores_codex":[0.9992504,0.0003082754,0.00002295351,0.0000952862,0.0001034013,0.0002196453],"domain_scores_gemma":[0.9988944,0.0001460895,0.0001260523,0.00006740504,0.0001128896,0.0006531442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8122028,0.02705969,0.008759258,0.001401943,0.002491116,0.0003345277,0.0004268036,0.002658627,0.01155695,0.0006437868,0.02338249,0.1090819],"study_design_scores_gemma":[0.8212768,0.1376027,0.02451063,0.00008378327,0.001227421,0.0002421195,0.0001363818,0.0007854371,0.0009992409,0.0002358154,0.01283458,0.00006511639],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9502436,0.0147176,0.0007026285,0.004657306,0.0005050848,0.007433338,0.01064435,0.0001691004,0.010927],"genre_scores_gemma":[0.9418556,0.01657299,0.00457874,0.005025383,0.000467078,0.005149713,0.0129885,0.0001082532,0.01325378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1016788,"threshold_uncertainty_score":0.2021738,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03639334982599422,"score_gpt":0.3302634596488522,"score_spread":0.293870109822858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}